Enzo Biochem to be acquired by Battery Ventures for $0.70/sh all-cash, ~$37M total

ENZO BIOCHEM INC

Battery Ventures will acquire Enzo for $0.70 per share in cash, total consideration ~$37 million.
Purchase price represents a 75% premium to April 22 close and ~32% premium to June 23 close.
Transaction expected to close in Q3 2025, subject to shareholder approval and customary conditions.
Board unanimously approved; officers, directors, and largest shareholder have support agreements to vote in favor.
Enzo will become privately held; shares will no longer be listed on public exchanges.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.